Polymyositis

The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient
G J D Hengstman, W J van Venrooij, J Vencovsky, H M Moutsopoulos, B G M van Engelen

Annals of the Rheumatic Diseases Feb 2000, 59 (2) 141-142; DOI: 10.1136/ard.59.2.141
First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort
Masatoshi Jinnin, Akiko Ohta, Shoichiro Ishihara, Hirofumi Amano, Tatsuya Atsumi, Manabu Fujimoto, Takashi Kanda, Yasushi Kawaguchi, Atsushi Kawakami, Akio Mimori, Tsuneyo Mimori, Toshihide Mimura, Yoshinao Muro, Hajime Sano, Jun Shimizu, Tsutomu Takeuchi, Yoshiya Tanaka, Kazuhiko Yamamoto, Takayuki Sumida, Hitoshi Kohsaka

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 387-392; DOI: 10.1136/annrheumdis-2019-215488
Comment on: ‘Idiopathic inflammatory myopathies and antisynthetase syndrome: contribution of antisynthetase antibodies to improve current classification criteria’ by Greco et al
Johannes Knitza, Lorenzo Cavagna, Georg Schett, Jörg H W Distler

Annals of the Rheumatic Diseases Jul 2020, 79 (7) e85; DOI: 10.1136/annrheumdis-2019-215484
On using machine learning algorithms to define clinically meaningful patient subgroups
Iago Pinal-Fernandez, Andrew Lee Mammen

Annals of the Rheumatic Diseases Oct 2020, 79 (10) e128; DOI: 10.1136/annrheumdis-2019-215852
On how to not misuse hierarchical clustering on principal components to define clinically meaningful patient subgroups. Response to: ‘On using machine learning algorithms to define clinical meaningful patient subgroups’ by Pinal-Fernandez and Mammen
Alain Meyer, Lionel Spielmann, François Séverac

Annals of the Rheumatic Diseases Oct 2020, 79 (10) e129; DOI: 10.1136/annrheumdis-2019-215868
Immune checkpoint inhibitor rechallenge in patients with immune-related myositis
Julie Delyon, Florence Brunet-Possenti, Sarah Leonard-Louis, Dimitri Arangalage, Mathilde Baudet, Barouyr Baroudjian, Celeste Lebbe, Baptiste Hervier

Annals of the Rheumatic Diseases Nov 2019, 78 (11) e129; DOI: 10.1136/annrheumdis-2018-214336
Anti-Ku syndrome with elevated CK and anti-Ku syndrome with anti-dsDNA are two distinct entities with different outcomes
Lionel Spielmann, Benoit Nespola, François Séverac, Emmanuel Andres, Romain Kessler, Aurélien Guffroy, Vincent Poindron, Thierry Martin, Bernard Geny, Jean Sibilia, Alain Meyer

Annals of the Rheumatic Diseases Aug 2019, 78 (8) 1101-1106; DOI: 10.1136/annrheumdis-2018-214439
Augmented versus artificial intelligence for stratification of patients with myositis
Michael Mahler, Brenden Rossin, Olga Kubassova

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e162; DOI: 10.1136/annrheumdis-2019-216000
Response to: ‘Semi-quantitative analysis of line blot assay for myositis-specific and myositis-associated antibodies: a better performance?’ by Cavazzana et al
Johan Rönnelid, Fabricio Espinosa-Ortega, Ingrid E Lundberg

Annals of the Rheumatic Diseases Nov 2020, 79 (11) e153; DOI: 10.1136/annrheumdis-2019-215967
Shared genetic factors and their causality in autoimmune diseases
Kazuhiko Yamamoto, Yukinori Okada

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1449-1451; DOI: 10.1136/annrheumdis-2019-215099

Main menu

Polymyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Polymyositis

Pages